Form 4: TransMedics Group Executive Tamer Khayal Executes Stock Options and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4


Tamer Khayal, Chief Commercial Officer of TransMedics Group, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan on September 3, 2024.

Summary

  • On September 3, 2024, Tamer Khayal, the Chief Commercial Officer of TransMedics Group, Inc. (TMDX), executed stock options and sold shares of common stock.
  • These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan established on September 6, 2023.
  • Khayal exercised options to acquire 1,459 shares at $38.46, 417 shares at $66.10, and 1,084 shares at $13.28.
  • He then sold 599 shares at an average price of $157.27, 921 shares at $158.09, 132 shares at $159.02, 396 shares at $160.67, 700 shares at $161.54, 80 shares at $163.09, 32 shares at $164.68, and 100 shares at $165.87.
  • Following these transactions, Khayal directly owns 20,843 shares of TransMedics Group, Inc. common stock.
  • He also holds options to purchase 8,750 shares at $38.46, 12,515 shares at $66.10, and 19,500 shares at $13.28, which vest monthly until February 2025, February 2027 and February 2026 respectively.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of insider trading activity under a pre-arranged plan. There's no indication of positive or negative news about the company.

Positives

  • The transactions were conducted under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.

Risks

  • Executive stock sales can sometimes be perceived negatively by investors, although the existence of a 10b5-1 plan mitigates this concern.

Industry Context

Insider transactions are common in publicly traded companies and are closely monitored by investors and regulators. The use of 10b5-1 plans is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

  • Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
  • Rule 10b5-1 trading plans are a common tool used by corporate insiders to manage their stock holdings in a transparent and compliant manner.
  • The vesting schedules of the options are typical for executive compensation packages.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership, but the existence of a 10b5-1 plan suggests the sales were planned and not based on any inside information.

Key Dates

DateDescription
09/06/2023Date of establishment of the Rule 10b5-1 trading plan.
02/24/2025Date when the first stock option grant will be fully vested.
02/22/2026Date when the third stock option grant will be fully vested.
02/20/2027Date when the second stock option grant will be fully vested.
09/03/2024Date of the reported transactions (stock option exercises and share sales).
09/05/2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.